Craft

Lantern Pharma

Stock Price

$4

2023-11-30

Market Capitalization

$42.9 M

2023-11-30

Lantern Pharma Summary

Company Summary

Overview
Lantern Pharma is a biotechnology company developing precision cancer drugs. It offers therapies using genomic data, machine learning, and computational biology modeling to identify the patient groups most likely to respond to therapy and to clarify the potential underlying mechanism(s) of action.
Type
Public
Status
Active
Founded
2013
HQ
Dallas, TX, US | view all locations
Website
http://www.lanternpharma.com/
Cybersecurity rating
Sectors

Key People

  • Panna Sharma

    Panna Sharma, Chief Executive Officer, President and Director

  • David R. Margrave

    David R. Margrave, Chief Financial Officer and Secretary

  • Peter Nara
  • Reggie Ewesuedo

    Reggie Ewesuedo, Vice President, Clinical Development

    LocationsView all

    1 location detected

    • Dallas, TX HQ

      United States

      1920 McKinney Ave 7th Floor

    Lantern Pharma Financials

    Summary Financials

    Net income (Q3, 2023)
    ($3.2M)
    Cash (Q3, 2023)
    $25.6M
    EBIT (Q3, 2023)
    ($3.5M)
    Enterprise value
    $17.6M

    Footer menu